Experience with the vacuum-enhanced tumescence ErecAid system in the treatment of erectile impotence among diabetic patients in Saudi Arabia
✍ Scribed by Famuyiwa, O O ;Al-Jasser, S J ;Ahmad, A S ;Al-Nuaim, A A ;Yaqub, B ;Sulimani, R A
- Publisher
- John Wiley and Sons
- Year
- 1992
- Tongue
- English
- Weight
- 469 KB
- Volume
- 9
- Category
- Article
- ISSN
- 1357-8170
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Twenty diabetic patients (16 NIDDM, 4 IDDM) were managed for erectile impotence using a non‐surgical device‐the vacuum erection device (VED). Their ages ranged from 27 to 71 years with a mean of 50.4 and diabetes duration ranged from 6 to 21 years with a mean of 11.5 years. Duration of impotence ranged from one to 10 years with a mean of 3.3 years and the aetiology was neurogenic and/or psychogenic. One to 14 months after prescribing the device, (mean 3.7 months), four patients rated the system poorly while 16 expressed satisfaction with it. Faulty technique in use of the device was successfully corrected in two of the four and, overall, 18 patients (90%) expressed satisfaction with the VED, scoring it an average 7.7 out of 10 in its ability to correct impotence. Four spouses (20%) had sexual dissatisfaction, six patients (30%) had transient penile discomfort and there was impaired ejaculation in four patients (20%). The VED was effective and safe in managing erectile impotence of neurogenic or psychogenic orgin in Saudi diabetic patients. It was relatively easy to use and culturally acceptable. It could be particularly useful for treating erectile failure among diabetic patients in developing countries.